Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
366 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Icon Cancer Centre Wesley
Auchenflower, Australia
Adam StirlingRecruiting - Sunshine Coast University Hospital
Birtinya, Australia
Bryan ChanRecruiting - Austin Health
Heidelberg, Australia
Sagun ParakhRecruiting - Icon Cancer Centre - Kurralta Park
Kurralta Park, Australia
Dainik PatelRecruiting - Tamworth Hospital
North Tamworth, Australia
Sunil RaiRecruiting - Sir Charles Gairdner Hospital
Perth, Australia
samantha bowyerRecruiting - Goulburn Valley Health
Shepparton, Australia
Myron KlevanskyRecruiting - Latrobe Regional Health
Traralgon, Australia
Nguyen ChauRecruiting
- Medizinische Universität Graz
Graz, Austria
Gudrun AbsengerRecruiting - Ordensklinikum Linz Gmbh Elisabethinen
Linz, Austria
Michael SchumacherRecruiting - Klinik Floridsdorf
Vienna, Austria
Maximilian HochmairRecruiting
- Chirec - Site Delta
Auderghem, Belgium
Christophe CompèreRecruiting - Antwerp University Hospital
Edegem, Belgium
Jo RaskinRecruiting - Uz Leuven
Leuven, Belgium
christophe DoomsRecruiting - Az Delta Vzw
Roeselare, Belgium
Ingel DemedtsRecruiting
- Fundação Pio Xii - Hospital de Câncer de Barretos
Barretos, Brazil
Dayana Mendes RibeiroRecruiting - Oncocentro de Minas Gerais
Belo Horizonte, Brazil
Flavia DuarteRecruiting - Cto - Centro de Tratamento Oncológico
Belém, Brazil
Bruno FernandesRecruiting - Hospital Tacchini
Bento Gonçalves, Brazil
ANDRE REIRIZRecruiting - Centro de Pesquisa Sao Lucas
Campinas, Brazil
Rafael CarmoRecruiting - Centro de Pesquisa Clínica Do Instituto Do Câncer Do Ceará
Fortaleza, Brazil
Fabio ChavesRecruiting - Hospital de Cancer de Londrina
Londrina, Brazil
Mariana PiovesanaRecruiting - Liga Norte Riograndense Contra O Câncer
Natal, Brazil
Sulene OliveiraRecruiting - Hospital São Lucas Da Pucrs
Porto Alegre, Brazil
Ana Caroline GelattiRecruiting - Centro de Tratamento de Tumores Botafogo Para Oncoclinicas Rio de Janeiro Sa
Rio de Janeiro, Brazil
Tatiane MontellaRecruiting - Instituto D'Or Pesquisa E Ensino
Rio de Janeiro, Brazil
Clarissa Serodio da Rocha BaldottoRecruiting - Centro Paulista de Oncologia Clínica
São Paulo, Brazil
William Nassib William JuniorRecruiting - Hospital Santa Catarina - Paulista
São Paulo, Brazil
Gregorio SoaresRecruiting - Hospital Sírio Libanês
São Paulo, Brazil
Guilherme HaradaRecruiting - Icesp - Instituto Do Câncer Do Estado de São Paulo
São Paulo, Brazil
Gilberto CastroRecruiting - Instituto D'Or de Pesquisa E Ensino (idor)
São Paulo, Brazil
Milena Perez MakRecruiting
- K2 Oncology
Providencia, Chile
pablo Rodriguez MonarcaNot, yet, recruiting - Bradfordhill
Santiago, Chile
Carlos RojasNot, yet, recruiting - Centro de Oncología de Precisión
Santiago, Chile
Pamela SalmanNot, yet, recruiting - Falp
Santiago, Chile
Rodrigo UribeNot, yet, recruiting
- Anyang Cancer Hospital
Anyang, China
Yaowen ZhangRecruiting - Beijing Cancer Hospital
Beijing, China
Shi YanRecruiting - Cancer Hospital Chinese Academy of Medical Science
Beijing, China
Nan BiRecruiting - China-Japan Friendship Hospital
Beijing, China
Guangying ZhuRecruiting - Peking University People'S Hospital
Beijing, China
Fan YangRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Mar 2025
- Primary completion
- 31 May 2029
- Completion
- 29 Feb 2032
- Last update posted
- 7 Jul 2026
- Registered enrollment
- 700
- Registry id
- NCT06890598
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.